search
Front > News

Teva invests in ADD treatment co Alcobra

22 Feb, 2011 18:12
שלח תגובה במיילGali Weinreb

The Israeli start-up has developed a drug based on a molecule for neutralizing the influence of alcohol on cognitive functions.

Sources inform ''Globes'' that Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) has signed a strategic agreement with Israeli start-up Alcobra Ltd., which has developed a treatment for attention deficit disorder (ADD) based on an existing drug.

The agreement is similar to other agreements Teva has signed with CureTech Ltd., CellCure Neurosciences Ltd., Mediwound Ltd. and other companies. Teva will finance full development of Alcobra's product and will have the right to acquire the company for at least several tens of millions of dollars. Teva will make an initial investment of a few million dollars into the company.

Closing of the agreement is subject to approvals that Teva and Alcobra must obtain.

Alcobra was founded by Udi Gilboa and Dr. Dalia Megiddo in 2008, and they, together with other investors, have invested several million dollars in the company to date. Gilboa is managing director of TopNotch Capital, a boutique investment bank that specializes in the life sciences, and Megiddo is the managing partner in Expedio Ventures (formerly 7 Health Ventures).

Since Alcobra's product is based on a drug that is already on the market, it will have to undergo only a brief series of clinical trials. The company has already begun an expanded Phase IIb trial (multicenter efficacy trial) on 120 patients, which will take about nine months. The Phase I clinical trial (safety and efficacy trial) on 40 adult patients with ADD showed statistically significant improvement in selected cognitive measures.

Hadassah Medical Organization conducted a Phase I clinical trial of this drug developed by Alcobra to neutralize the influence of alcohol on cognitive functions. The page describes the clinical trial of slow release Metadoxine formula, which found that one dose of the drug before consuming alcohol lowered the level of alcohol in the blood, dramatically improved motor and cognitive functions and decreased the craving for alcohol in the test participants.

Published by Globes [online], Israel business news - www.globes-online.com - on February 22, 2011

© Copyright of Globes Publisher Itonut (1983) Ltd. 2011

groundcover founders credit: Yossi Yarom Israeli observability co groundcover raises $35m

groundcover has developed a “Bring Your Own Cloud” (BYOC) observability solution, redefining the architecture of a modern observability platform.

Tel Aviv Stock Exchange credit: Shutterstock MagioreStock Foreign investment in TASE hits five-year high

Foreign investors have been flocking to the Tel Aviv Stock Exchange in recent weeks, the TASE research department tells "Globes."

Elbit Systems tank turret systems credit: Elbit Systems Elbit Systems wins $100m tank turret systems deal

The Israel defense electronics company will supply its advanced UT30 MK2 unmanned turret systems to General Dynamics European Land Systems (GDELS) to be supplied to a NATO European country.

Tomer Weingarten Photo: PR Trump targets SentinelOne exec in act of revenge

The US administration has suspended the security clearance of the company's chef intelligence and public policy officer Chris Krebs and everyone associated with him.

Tel Aviv Stock Exchange share prices rising credit: Tali Bogdanovsky TASE opens sharply higher after Trump U-turn on tariffs

The pause is being interpreted as a climb down after US President Donald Trump admitted he had made the move to calm the markets.

Ashot Ashkelon credit: Ministry of Defense Up 250%, Ashot Ashkelon wins another Defense Ministry order

The Israeli defense company's share price has risen 250% in the past three years since FIMI Opportunity Funds acquired control.

Liad Agmon credit: Eyal Izhar Insight Partners Liad Agmon steps down as managing partner

Serial entrepreneur Agmon has served as a partner at Insight Partners Israel alongside Daniel Aronovitz who set up the Israel office.

Shekels credit: Shutterstock Vladerina32 Shekel slide resumes amid escalating tariff war

The Bank of Israel is not expected to intervene in the forex market despite the sharp depreciation of the shekel.

Nir Zuk credit: Inbal Marmari Palo Alto Networks mulls buying AI security co for $700m

Sources inform "Globes" that on Palo Alto's radar is Protect AI.

President Donald Trump hosts Prime Minister Benjamin Netanyahu credit: Reuters Kevin Mohatt Israeli officials confident on US tariff concessions

Senior Israeli figures believe that concessions could be tied to progress on strategic regional political issues that are important to President Trump.

Phoenix Investment House CEO Avner Hadad credit: Tommy Harpaz "The market has priced in all the bad things"

Phoenix Investment House CEO Avner Hadad says US markets could continue to fall, but that we are close to interesting territory for patient investors.

Tel Aviv credit: Shutterstock Tel Aviv slips in World's Wealthiest Cities ranking

Tel Aviv's position as one of the world's wealthiest cities took a big knock over the past year as it slipped from 42nd to 48th in investment advisors Henley & Co.'s "World's Wealthiest Cities" Top 50 ranking.

Leviathan platform credit: Albatross C'ttee seen recommending no cut in gas exports

The Dayan committee on the future of the gas sector estimates that Israel's natural gas reserves will run out in 2045.

Accountant General Yali Rothenberg credit: Rafi Kutz Israel's fiscal deficit continues to narrow

The deficit narrowed in the twelve months to the end of March 2025, for the sixth consecutive month, Ministry of Finance accountant general Yali Rothenberg reported today.

Arkia credit: Arkia Arkia cuts Tel Aviv - New York April fares

Arkia has cut fares at the last minute, a time when prices usually soar even higher, according to the pricing method used in the industry.

Bank of Israel Governor Prof. Amir Yaron credit: Dani Shem Tov Knesset Spokesperson BoI Governor: US tariffs could push up inflation in Israel

Prof. Amir Yaron tells "Globes" that there is a risk that the new tariffs will cause inflation to rise in the US, with a knock-on effect for Israel.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018